Notice Pursuant to the National Cooperative Research and Production Act of 1993-Customer Experience Hub

<html>
<head>
<title>Federal Register, Volume 91 Issue 1 (Friday, January 2, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 1 (Friday, January 2, 2026)]
[Notices]
[Page 163]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-24167]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Customer Experience Hub

    Notice is hereby given that, on July 1, 2025, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), The Customer Experience Hub (``CX 
Hub'') has filed written notifications simultaneously with the Attorney 
General and the Federal Trade Commission disclosing changes in its 
membership. The notifications were filed for the purpose of extending 
the Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances.
    Specifically, Allegheny-Singer Research Institute dba Highmark 
Health Research Institute, Pittsburgh, PA; AeroClenz, Inc., Fort Myers, 
FL; Allucent Government Services (US) LLC, Cary, NC; American Society 
of Clinical Oncology, Inc., Alexandria, VA; AstraZeneca Pharmaceuticals 
LP, Washington, DC; BelleTorus Corp., Cambridge, MA; BioImaginix LLC, 
Morgantown, WV; BioMedSA, San Antonio, TX; Bold Insight, Inc., Downers 
Grove, IL; Bracane Company, Plano, TX; Building Healthier America, 
Hudson, WI; Consuli, Inc., San Diego, CA; Digital Infuzion LLC, 
Rockville, MD; DLH LLC, Bethesda, MD; Elizabeth Glaser Pediatric AIDS 
Foundation, Washington, DC; Fralin Biomedical Research Institute at 
VTC, Roanoke, VA; Genomic Expression, Inc., Beverly, MA; Georgia Life 
Sciences, Atlanta, GA; Hello Heart, Inc., Menlo Park, CA; Humano Tech, 
Inc., Atlanta, GA; International Consulting Associates, Inc., 
Arlington, VA; linedanceAI, Richardson, TX; LivAi, Inc., San Francisco, 
CA; Massive Bio, Inc., New York, NY; Medblocks, Inc., Bengaluru, 
REPUBLIC OF INDIA; OpenOme, Inc. dba OpenCures, Novato, CA; Pancreatic 
Cancer Action Network, El Segundo, CA; Probably Genetic, Inc., San 
Francisco, CA; Progeneer, Inc., Seoul, REPUBLIC OF KOREA; Reinvent 
Health Information Technology LLC, Lexington, KY; Surgo Health P.B.C, 
Washington, DC; TrialAssure, Inc., Canton, MI; Unicorn Biotechnologies, 
Inc., Newark, NJ; University of South Carolina, Columbia, SC; Upstream 
Thinking LLC, Austin, TX; Veridat LLC, Toledo, OH; Viinetwork, Inc. dba 
Hiive Health, Washington, DC; and WHOOP, Inc., Boston, MA have been 
added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and the CX Hub intends to file 
additional written notifications disclosing all changes in membership.
    On January 11, 2024, the CX Hub filed its original notification 
pursuant to section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to section 6(b) of 
the Act on April 16, 2024 (89 FR 26929).
    The last notification was filed with the Department on April 1, 
2025. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on June 13, 2025 (90 FR 25082).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2025-24167 Filed 12-31-25; 8:45 am]
BILLING CODE P


</pre></body>
</html>

Notice Pursuant to the National Cooperative Research and Production Act of 1993-Customer Experience Hub

Federal Register Citation

Suggested Web Citation